CT spots cardiac signs in pulmonary embolism

Article

Radiologists interpreting scans of patients with suspected pulmonary embolism should check for signs of right heart dysfunction. This could save a life, according to a study presented at the meeting of the American Roentgen Ray Society in May.

Radiologists interpreting scans of patients with suspected pulmonary embolism should check for signs of right heart dysfunction. This could save a life, according to a study presented at the meeting of the American Roentgen Ray Society in May.

Patients with PE often die due to acute right heart failure, said lead author Dr. Benjamin Zalta. Patients with PE and right valve dilation have increased mortality rates.

"CT can be diagnostic of pulmonary embolism and also has prognostic implications," Zalta said.

Zalta and colleagues at Albert Einstein College of Medicine and the Montefiore Medical Center in New York City retrospectively examined 74 consecutive adults who had been diagnosed with PE on either a four- or 16-slice CT scanner. Thirty-four subjects had received echocardiography as well.

The researchers diagnosed right heart dysfunction in patients with dilated right ventricles or an interventricular septum that flattened or bowed into the left ventricle. They also determined clot burden.

Sixty-six percent of patients had CT findings of right heart dysfunction, while nearly 50% had clot burdens greater than or equal to 30% pulmonary vascular obstruction.

CT showed a significant difference between the mean clot burden in patients with right heart dysfunction (49) and those without (25). Echocardiography showed no such significant difference.

Sensitivity and specificity for CT were 81% and 47%, respectively, compared with echocardiography's 56% and 42%. Four echo studies did not provide adequate images.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.